المؤلفون: Kathryn AF Pennel, Jean A Quinn, Colin Nixon, Jitwadee Inthagard, Hester C vanWyk, David Chang, Selma Rebus, GPOL Group, Jennifer Hay, Noori N Maka, Campbell SD Roxburgh, Paul G Horgan, Donald C McMillan, James H Park, Antonia K Roseweir, Colin W Steele, Joanne Edwards

المصدر: The Journal of Pathology: Clinical Research, Vol 8, Iss 6, Pp 509-520 (2022)

مصطلحات موضوعية: CXCL8, CXCR2, colorectal cancer, sidedness, stromal invasion, tumour microenvironment, Pathology, RB1-214

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2056-4538

URL الوصول: https://doaj.org/article/2587601ff4f442529788ab8eca02bcc0

المؤلفون: Knight K; Academic Unit of Surgery, Glasgow Royal Infirmary, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK., Bigley C; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Pennel K; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Hay J; Glasgow Tissue Research Facility, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK., McMillan D; Academic Unit of Surgery, Glasgow Royal Infirmary, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK., Park J; Academic Unit of Surgery, Glasgow Royal Infirmary, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.; Department of Surgery, Queen Elizabeth University Hospital, Glasgow, UK., Roxburgh C; Academic Unit of Surgery, Glasgow Royal Infirmary, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK.

المصدر: The journal of pathology. Clinical research [J Pathol Clin Res] 2024 Jul; Vol. 10 (4), pp. e12385.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101658534 Publication Model: Print Cited Medium: Internet ISSN: 2056-4538 (Electronic) Linking ISSN: 20564538 NLM ISO Abbreviation: J Pathol Clin Res Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/diagnosis , Tumor Microenvironment* , Biomarkers, Tumor*/analysis, Humans ; Prognosis ; Neoplasm Grading

المؤلفون: Domingo E; Department of Oncology, University of Oxford, Oxford, United Kingdom.; CRUK Beatson Institute of Cancer Research, Garscube Estate, Glasgow, United Kingdom., Kelly C; CRUK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Sansom O; CRUK Beatson Institute of Cancer Research, Garscube Estate, Glasgow, United Kingdom., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Oien K; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Iveson T; University of Southampton, Southampton, United Kingdom., Saunders M; The Christie NHS Foundation Trust, Manchester, United Kingdom., Kerr R; Department of Oncology, University of Oxford, Oxford, United Kingdom., Tomlinson I; Department of Oncology, University of Oxford, Oxford, United Kingdom., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Harkin A; CRUK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Nowak M; Department of Pathology and Molecular Pathology, Zurich, Switzerland., Koelzer V; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Pathology and Molecular Pathology, Zurich, Switzerland., Easton A; Department of Oncology, University of Oxford, Oxford, United Kingdom., Boukovinas I; Medical Oncology Unit Department, Bioclinic Oncology Unit of Thessaloniki, Thessaloniki, Greece., Moustou E; Pathology, University Hospital of Heraklion, Crete, Greece., Messaritakis I; Laboratory of Translational Oncology, University of Crete-School of Medicine, Heraklion, Greece., Chondrozoumaki M; Laboratory of Tumor Cell Biology, University of Crete - School of Medicine, Heraklion, Greece., Karagianni M; Laboratory of Translational Oncology, University of Crete-School of Medicine, Heraklion, Greece., Pagès F; INSERM, Laboratory of Integrative Cancer Immunology, Sorbonne Université, Université de Paris Cité, Cordeliers Research Center, Paris, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Immunomonitoring Platform, Georges Pompidou European Hospital, Paris, France., Arnoux F; VERACYTE, Marseille, France., Lautard C; VERACYTE, Marseille, France., Lovera Y; VERACYTE, Marseille, France., Boquet I; VERACYTE, Marseille, France., Catteau A; VERACYTE, Marseille, France., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Sorbonne Université, Université de Paris Cité, Cordeliers Research Center, Paris, France.; VERACYTE, Marseille, France., Souglakos I; Laboratory of Translational Oncology, University of Crete-School of Medicine, Heraklion, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Greece., Church DN; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

مؤلفون مشاركون: TransSCOT Consortium

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 20; Vol. 42 (18), pp. 2207-2218. Date of Electronic Publication: 2024 Mar 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/mortality , Colorectal Neoplasms*/immunology , Leucovorin*/therapeutic use , Leucovorin*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Fluorouracil*/administration & dosage , Fluorouracil*/therapeutic use , Organoplatinum Compounds*/therapeutic use , Organoplatinum Compounds*/administration & dosage , Neoplasm Staging*, Humans ; Female ; Male ; Middle Aged ; Aged ; Prognosis ; Capecitabine/administration & dosage ; Capecitabine/therapeutic use ; Predictive Value of Tests ; Disease-Free Survival ; Oxaliplatin/therapeutic use ; Oxaliplatin/administration & dosage ; Adult ; Chemotherapy, Adjuvant ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Deoxycytidine/administration & dosage

SCR Protocol: Folfox protocol

المؤلفون: Galbraith NJ; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom; Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom. Electronic address: norman.galbraith@glasgow.ac.uk., Quinn JA; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., Al-Badran SS; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., Pennel KAF; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., Hillson LVS; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., Hatthakarnkul P; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., McKenzie M; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., Maka N; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Loi L; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., Frixou M; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom., Steele CW; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom; Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom., Roxburgh CS; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom; Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom., Horgan PG; Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom., McMillan DC; Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom., Edwards J; School of Cancer Sciences, Wolfson-Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom.

المصدر: Translational oncology [Transl Oncol] 2024 Oct; Vol. 48, pp. 102064. Date of Electronic Publication: 2024 Jul 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE

المؤلفون: Hatthakarnkul P; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Biomedical Science Program, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Pennel K; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Alexander P; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Academic Unit of Surgery, University of Glasgow, UK., van Wyk H; Academic Unit of Surgery, University of Glasgow, UK., Roseweir A; School of Medicine, University of Glasgow, Glasgow, UK., Inthagard J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Hay J; Glasgow Tissue Research Facility, Queen Elizabeth University Hospital, Glasgow, UK., Andersen D; Bioclavis Ltd, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Department of Pathology, Queen Elizabeth Hospital, Glasgow, UK., Park J; Department of Surgery, Queen Elizabeth University Hospital, Glasgow, UK., Roxburgh C; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Academic Unit of Surgery, University of Glasgow, UK., Thuwajit C; Biomedical Science Program, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., McMillan D; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Academic Unit of Surgery, University of Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK.

المصدر: The journal of pathology. Clinical research [J Pathol Clin Res] 2024 May; Vol. 10 (3), pp. e12374.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101658534 Publication Model: Print Cited Medium: Internet ISSN: 2056-4538 (Electronic) Linking ISSN: 20564538 NLM ISO Abbreviation: J Pathol Clin Res Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment* , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/surgery, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Prognosis ; Aged, 80 and over ; Adult

المؤلفون: Pennel KAF; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK. kathryn.pennel@glasgow.ac.uk., Hatthakarnkul P; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Wood CS; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK., Lian GY; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Al-Badran SSF; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Quinn JA; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Legrini A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Inthagard J; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Alexander PG; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK., van Wyk H; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK., Kurniawan A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Hashmi U; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; University of Glasgow Medical School, Glasgow, G12 8QQ, UK., Gillespie MA; CRUK Scotland Institute, Glasgow, G61 1BD, UK., Mills M; CRUK Scotland Institute, Glasgow, G61 1BD, UK., Ammar A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Hay J; Glasgow Tissue Research Facility, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK., Andersen D; Bioclavis Ltd, Glasgow, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK., Nixon C; CRUK Scotland Institute, Glasgow, G61 1BD, UK., Rebus S; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Chang DK; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK., Kelly C; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK., Harkin A; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK., Graham J; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK., Church D; Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Tomlinson I; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK., Saunders M; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK., Iveson T; Southampton University Hospital NHS Foundation Trust, Southampton, SO16 6YD, UK., Lannagan TRM; CRUK Scotland Institute, Glasgow, G61 1BD, UK., Jackstadt R; CRUK Scotland Institute, Glasgow, G61 1BD, UK., Maka N; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK., Horgan PG; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK., Roxburgh CSD; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK., Sansom OJ; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; CRUK Scotland Institute, Glasgow, G61 1BD, UK., McMillan DC; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK., Steele CW; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.; CRUK Scotland Institute, Glasgow, G61 1BD, UK., Jamieson NB; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Park JH; Department of Surgery, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK., Roseweir AK; University of Glasgow Medical School, Glasgow, G12 8QQ, UK., Edwards J; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 01; Vol. 43 (1), pp. 64. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/metabolism, Humans ; Animals ; Mice ; Retrospective Studies ; Signal Transduction ; Hypoxia ; Keratins/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; Cell Line, Tumor

المؤلفون: Frei AL; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland., McGuigan A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sinha RRAK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jabbar F; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gneo L; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tomasevic T; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Iveson T; Southampton University, Southampton, UK., Saunders MP; The Christie NHS Foundation Trust, Manchester, UK., Oien KA; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Pezzella F; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Campo L; Department of Oncology, University of Oxford, Oxford, UK., Browne M; Department of Oncology, University of Oxford, Oxford, UK., Glaire M; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Danielsen HE; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom O; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Cancer Research UK Beatson Institute of Cancer Research, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Kerr R; Department of Oncology, University of Oxford, Oxford, UK., Kerr D; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Domingo E; Department of Oncology, University of Oxford, Oxford, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Church DN; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: david.church@well.ox.ac.uk., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK.

مؤلفون مشاركون: TransSCOT consortium

المصدر: The Lancet. Oncology [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. 198-211.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/pathology , Colorectal Neoplasms*/pathology, Humans ; Retrospective Studies ; Prognosis ; Lymphocytes, Tumor-Infiltrating ; Forkhead Transcription Factors/therapeutic use ; Neoplasm Staging

المؤلفون: Frei AL; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland., McGuigan A; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sinha RR; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Glaire MA; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jabbar F; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gneo L; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tomasevic T; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Iveson TJ; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Saunders M; The Christie NHS Foundation Trust, Manchester, UK., Oein K; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Pezella F; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK., Campo L; Department of Oncology, University of Oxford, Oxford, UK., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom OJ; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Cancer Research UK Scotland Centre, Edinburgh and Glasgow, UK., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Kerr DJ; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK., Danielsen HE; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.; Department of Informatics, University of Oslo, Oslo, Norway., Domingo E; Department of Oncology, University of Oxford, Oxford, UK.; Cancer Research UK Scotland Centre, Edinburgh and Glasgow, UK., Church DN; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.

مؤلفون مشاركون: TransSCOT Consortium

المصدر: The journal of pathology. Clinical research [J Pathol Clin Res] 2023 Nov; Vol. 9 (6), pp. 449-463. Date of Electronic Publication: 2023 Sep 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101658534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2056-4538 (Electronic) Linking ISSN: 20564538 NLM ISO Abbreviation: J Pathol Clin Res Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*/analysis , Neoplasms*, Humans ; Immunohistochemistry ; Image Processing, Computer-Assisted/methods ; Tissue Array Analysis

المؤلفون: Hatthakarnkul P; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom.; Biomedical Science Program, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Ammar A; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom., Pennel KAF; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom., Officer-Jones L; Cancer Research UK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Cusumano S; Cancer Research UK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Quinn JA; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom., Matly AAM; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom., Alexander PG; School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Alexandria Parade, Glasgow, United Kingdom., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Andersen D; BioClavis Ltd, Glasgow, United Kingdom., Lynch G; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom., van Wyk HC; School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Alexandria Parade, Glasgow, United Kingdom., Maka N; School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Alexandria Parade, Glasgow, United Kingdom., McMillan DC; School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Alexandria Parade, Glasgow, United Kingdom., Le Quesne J; Cancer Research UK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom., Thuwajit C; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Edwards J; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Glasgow, United Kingdom.

المصدر: Journal of Cancer [J Cancer] 2023 Jun 19; Vol. 14 (10), pp. 1837-1847. Date of Electronic Publication: 2023 Jun 19 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE

المؤلفون: Saunders MP; The Christie, Manchester, United Kingdom. Electronic address: mark.saunders8@nhs.net., Iype R; The Christie, Manchester, United Kingdom., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Crosby J; Queen Elizabeth University Department of Pathology and Biorepository, Glasgow, United Kingdom., Kerr R; University of Oxford, Oxford, United Kingdom., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Allan K; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., McQueen J; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Pearson SR; OCTO, University of Oxford, Oxford, United Kingdom., Cassidy J; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Medley LC; Royal United Hospital Bath, Bath, United Kingdom; South Devon Healthcare NHS Foundation Trust, Torquay, United Kingdom., Raouf S; Barts Health NHS Trust, London, United Kingdom., Harrison M; Mount Vernon Hospital, Northwood, United Kingdom., Brewster A; Velindre Cancer Centre, Cardiff, United Kingdom., Rees C; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom., Ellis R; Royal Cornwall Hospital, Truro, United Kingdom., Thomas AL; University of Leicester, Leicester, United Kingdom., Churn M; Worcester Royal Hospital, Worcester, United Kingdom., Iveson T; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Maka N; Queen Elizabeth University Department of Pathology and Biorepository, Glasgow, United Kingdom.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2023 Jun; Vol. 22 (2), pp. 231-237. Date of Electronic Publication: 2023 Feb 22.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology, Humans ; Disease-Free Survival ; Prognosis ; Oxaliplatin/therapeutic use ; Chemotherapy, Adjuvant ; Neoplasm Staging ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Retrospective Studies